| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $86.3M | — | -1.1% |
| Cost of Revenue | $38.3M | — | -2.9% |
| R&D Expense | $7.4M | — | -9.7% |
| SG&A Expense | $24.2M | — | +24.1% |
| Operating Income | $3.1M | — | -62.5% |
| Pre-tax Income | $582K | — | -88.2% |
| Income Tax | $76K | — | -98.3% |
| Net Income | $506K | — | +10.2% |
| EPS (Basic) | $0.03 | — | +0.0% |
| EPS (Diluted) | $0.03 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.4M | +42.5% | +249.9% |
| Accounts Receivable | $50.9M | -7.4% | -10.0% |
| Inventory | $958K | +53.8% | +61.0% |
| Current Assets | $109.7M | +4.8% | +25.6% |
| Total Assets | $407.5M | +1.2% | +4.8% |
| Current Liabilities | $61.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.5M | — | +168.3% |
| Capital Expenditures | $1.1M | — | +200.6% |
| Investing Cash Flow | -$2.7M | — | -21.9% |
| Financing Cash Flow | -$2.2M | — | +62.3% |
| Free Cash Flow | $14.4M | — | +166.1% |
| +19.0% |
| Long-term Debt | $163.9M | -0.5% | -2.4% |
| Total Liabilities | $228.9M | +1.9% | +3.9% |
| Stockholders' Equity | $178.7M | +0.4% | +6.0% |